China Health Industries Holdings Incの主要な財務諸表は何ですか?
CHHEの主要な財務比率は何ですか?
China Health Industries Holdings Incの収益はセグメントまたは地域別にどのように分けられていますか?
China Health Industries Holdings Incは収益を上げていますか?
China Health Industries Holdings Incに負債はありますか?
China Health Industries Holdings Incの発行済株式数は何株ですか?
主要データ
前終値
$0.0001
始値
$0
当日レンジ
$0 - $0
52週レンジ
$0 - $0.2225
取引高
1.0K
平均取引高
0
1株当たり利益(TTM)
-0.02
配当利回り
--
時価総額
$6.5K
CHHEとは何ですか?
China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm's products include soft capsule, hard capsule, tablet, granule, oral liquid forms which address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.